Cited by 966Bone Metabolism and DiseasesBone health and osteoporosis researchBone and Dental Protein Studies

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

Poole, Kenneth E. S., Van Bezooijen, Rutger L., Loveridge, Nigel, Hamersma, Herman, Papapoulos, Socrates E., Löwik, Clemens W., Reeve, Jonathan·2005·The FASEB Journal

DOI 10.1096/fj.05-4221fje

Open this paper in CoChat — free account

Abstract

Osteocytes are the most abundant cells in bone and are ideally located to influence bone turnover through their syncytial relationship with surface bone cells. Osteocyte‐derived signals have remained largely enigmatic, but it was recently reported that human osteocytes secrete sclerostin, an inhibitor of bone formation. Absent sclerostin protein results in the high bone mass clinical disorder sclerosteosis. Here we report that within adult iliac bone, newly embedded osteocytes were negative for sclerostin staining but became positive at or after primary mineralization. The majority of mature osteocytes in mineralized cortical and cancellous bone was positive for sclerostin with diffuse staining along dendrites in the osteocyte canaliculi. These findings provide for the first time in vivo evidence to support the concept that osteocytes secrete sclerostin after they become embedded in a mineralized matrix to limit further bone formation by osteoblasts. Sclerostin did not appear to influence the formation of osteocytes. We propose that sclerostin production by osteocytes may regulate the linear extent of formation and the induction or maintenance of a lining cell phenotype on bone surfaces. In doing so, sclerostin may act as a key inhibitory signal governing skeletal microarchitecture.

Integrity signals

Registry

Crossref · 10.1096/fj.05-4221fje

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
Winkler, D. G., Sutherland, M. K., Geoghegan, J. C., Yu, C., Hayes, T., Skonier, J. E., Shpektor, D., Jonas, M., Kovacevich, B. R., Staehling‐Hampton, K., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg599 · Cited by 1,114
Bone Dysplasia Sclerosteosis Results from Loss of the SOST Gene Product, a Novel Cystine Knot–Containing Protein
Brunkow, M. E., Gardner, J. C., Van Ness, J., Paeper, B. W., Kovacevich, B. R., Proll, S., Skonier, J. E., Zhao, L., Sabo, P. J., Fu, Y.-H., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318811 · Cited by 1,011
Self-citation
Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist
van Bezooijen, R. L., Roelen, B. A. J., Visser, A., van der Wee-Pals, L. J. A., de Wilt, E., Karperien, M., Hamersma, H. A., Papapoulos, S. E., ten Dijke, P., & Löwik, C. W. G. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031454 · Cited by 893
Self-citation
Loss of Osteocyte Integrity in Association with Microdamage and Bone Remodeling After Fatigue In Vivo
Verborgt, O., Gibson, G. J., & Schaffler, M. B. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.60 · Cited by 731
Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells
Dobnig, H., & Turner, R. T. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628403 · Cited by 614
Periosteum: biology, regulation, and response to osteoporosis therapies
Allen, M. R., Hock, J. M., & Burr, D. B. (2004) · Bone · doi:10.1016/j.bone.2004.07.014 · Cited by 449
The Death of Osteocytes via Apoptosis Accompanies Estrogen Withdrawal in Human Bone
Tomkinson, A., REEVE, J., Shaw, R. W., & Noble, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4200 · Cited by 417
Self-citation

Show all 34 references

Research works printed but not linked: 2

Warmington K., 2004, Sclerostin antagonism in adult rodents, via monoclonal antibody mediated blockade, increases bone mineral density and implicates sclerostin as a key regulator of bone mass during adulthood (Abstract), J. Back Musculoskeletal. Rehabil., 19, S56
10.1210/jc.82.9.3128 · DOI

Sorted by citations

Items 701–800 of 966

New and emerging treatments for osteoporosis
Clarke, B. L. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03541.x · Cited by 5
Coupled or uncoupled remodeling, is that the question?
Gasser, J. A. (2006) · PubMed · Cited by 5
Recapitulating bone development events in a customised bioreactor through interplay of oxygen tension, medium pH, and systematic differentiation approaches
Lee, P. S., Hess, R., Friedrichs, J., Hänchen, V., Eckert, H., Cuniberti, G., Rancourt, D. E., Krawetz, R. J., Hintze, V., Gelinsky, M., et al. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2921 · Cited by 4
Long noncoding RNA expression profiles in intermittent parathyroid hormone induced cementogenesis
Li, T., Wang, H., Xia, K., Wu, Z., Liu, R., Yin, X., Zhou, C., Li, Y., & Zou, S. (2020) · Genomics · doi:10.1016/j.ygeno.2020.12.012 · Cited by 4
Local and Systemic Regulation of Mineralization: Role of Coupling Factors, Pyrophosphate, Polyphosphates, Vitamin D, Fetuin, Matrix Gla Protein, and Osteopontin
Shapiro, I. M., & Landis, W. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-34304-9_9 · Cited by 5
The Impact of Non-bone Metastatic Cancer on Musculoskeletal Health
Galiana-Melendez, F., & Huot, J. (2024) · Current Osteoporosis Reports · doi:10.1007/s11914-024-00872-4 · Cited by 2
Osteocytes
Bonewald, L. F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00007-1 · Cited by 8
Olanzapine decreased osteocyte maturation and Wnt/β-catenin signaling during loading of the alveolar bone in rats
Disha-Ibrahimi, S., Furlani, B., Drevenšek, G., Hudoklin, S., Marc, J., Žitnik, I. P., Sajovic, J., & Drevenšek, M. (2022) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2022.7523 · Cited by 4
Functions and Metabolism of Amino Acids in Bones and Joints of Cats and Dogs
Lopez, A. N., Bazer, F. W., & Wu, G. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-54192-6_7 · Cited by 7
Selecting highly structure-specific antibodies using structured synthetic mimics of the cystine knot protein sclerostin
Back, J. W., Frisch, C. M., van Pee, K., Boschert, V., van Vught, R., Puijk, W. C., Mueller, T. D., Knappik, A., & Timmerman, P. (2012) · Protein Engineering Design and Selection · doi:10.1093/protein/gzs012 · Cited by 4
Bone Turnover and Vascular Calcification
Zheng, P. W. C. (2014) · Journal of Nephrology & Therapeutics · doi:10.4172/2161-0959.1000171 · Cited by 3
Epigenetic Regulation of Sost/sclerostin Expression
del Real, Á., Riancho, J. A., & Delgado‐Calle, J. (2017) · Current Molecular Biology Reports · doi:10.1007/s40610-017-0063-9 · Cited by 5
Should bone densitometry define osteoporosis in 2020? A current concepts review of the role of vibrational spectroscopy in the evaluation of bone health
Khalid, M., Khan, F., Baik, M., & Fazal, J. (2020) · Journal of Musculoskeletal Surgery and Research · doi:10.4103/jmsr.jmsr_31_20 · Cited by 4
WNT signaling in skeletal homeostasis and diseases
Gori, F., & Baron, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00012-5 · Cited by 4
All-trans Retinoic Acid and Beta-Carotene Increase Sclerostin Production in C2C12 Myotubes
Ewendt, F., Lehmann, A., Wodak, M. F., & Stangl, G. I. (2023) · Biomedicines · doi:10.3390/biomedicines11051432 · Cited by 4
Wnt Signaling and Bone
Johnson, M. L. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00013-6 · Cited by 4
Bone morphogenetic protein signaling is fine-tuned on multiple levels
Sieber, C., Schwaerzer, G. K., & Knaus, P. I. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8552-1_6 · Cited by 4
Histomorphometric and histological evaluations of the simvastatin effect on alveolar bone loss induced by cyclosporine A in rats
Hagar, S., Sahar, S., Mona, Y., & Mamdouh, N. (2015) · Indian Journal of Multidisciplinary Dentistry · doi:10.4103/2229-6360.163640 · Cited by 4
Genes and osteoporosis: time for a change in strategy
Giroux, S., & Rousseau, F. (2009) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.09.11 · Cited by 4
Le déplacement dentaire orthodontique : histologie, biologie et effets iatrogènes
Cuny-Houchmand, M., Chretien, N., Guéhennec, L. L., Deniaud, J., Renaudin, S., Boutigny, H., & Soueidan, A. (2009) · L Orthodontie Française · doi:10.1051/orthodfr/2009027 · Cited by 4
Biology, Physiology, and Morphology of Bone
Schett, G. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1738-9.00004-9 · Cited by 4
Anatomy and Physiology of Skeletal Tissue: The Bone Cells
Brunetti, G., Colaianni, G., Colucci, S. C., & Grano, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-75110-8_1 · Cited by 5
Progrès dans les maladies osseuses et le métabolisme phospho-calcique
Alexandre, C., Thomas, T., Lafage‐Proust, M., & Vico, L. (2007) · Revue du Rhumatisme · doi:10.1016/s1169-8330(07)80614-4 · Cited by 4
Cell biochemistry and function and the integration of biomedical research (location, location, location)
Loveridge, N. (2008) · Cell Biochemistry and Function · doi:10.1002/cbf.1535 · Cited by 4
Self-citation
Hepatic osteodystrophy: An underrecognized metabolic bone disease
Pramanik, S., Palui, R., & Ray, S. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i8.109093 · Cited by 5
Periodontitis as a Model for Inflammatory Uncoupling of Bone Remodeling
de Molon, R. S., Tetradis, S., Vernal, R., Leite, F. R. M., & Dyke, T. E. V. (2026) · Journal of Periodontal Research · doi:10.1111/jre.70148 · Cited by 5
The distribution of osteocytic lacunar–canalicular system, and immunolocalization of FGF23 and sclerostin in osteocytes
Amizuka, N., Hongo, H., Sasaki, M., Hasegawa, T., Suzuki, R., Tabata, C., Sobhan, U., Masuki, H., Guo, Y., de Freitas, P. H. L., et al. (2012) · Journal of Oral Biosciences · doi:10.1016/j.job.2011.06.002 · Cited by 3
Only bioactive forms of PTH (n-oxPTH and Met18(ox)-PTH) inhibit synthesis of sclerostin – evidence from in vitro and human studies
Li, M., Hasan, A. A., Chu, C., Hocher, J.-G., Liu, Y., Zhang, X., Chen, X., Yard, B. A., Krämer, B. K., & Hocher, B. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-02928-x · Cited by 3
Bone-Orchestrating Cells, Osteocytes
Hongo, H., Hasegawa, T., Sasaki, M., Suzuki, R., Masuki, H., Yamada, T., Shimoji, S., Kawanami, M., Yamamoto, T., & Amizuka, N. (2012) · Institutional Repositories DataBase (IRDB) · Cited by 3
Wnt signaling in bone
Bodine, P. V. N. (2007) · BoneKEy-Osteovision · doi:10.1138/20070255 · Cited by 3
Avances en el estudio de los mecanismos involucrados en la modulación de la expresión de esclerostina en células humanas
Delgado‐Calle, J., Pérez-Campo, F. M., & Riancho, J. (2014) · Revista de Osteoporosis y Metabolismo Mineral · doi:10.4321/s1889-836x2014000400006 · Cited by 3
Recombinant hormones in osteoporosis
Rejnmark, L. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.798295 · Cited by 3
Pathophysiology of CKD-MBD
Elder, G. J. (2011) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-011-9120-8 · Cited by 3
Alternated activation with relaxation of periosteum stimulates bone modeling and remodeling
Saulačić, N., Katagiri, H., Fujioka‐Kobayashi, M., Ferrari, S., & Gerbaix, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-61902-w · Cited by 7
Protein Expression Profiles Corresponding to Histological Changes with Denosumab Treatment in Giant Cell Tumors of Bone
Suehara, Y., Okubo, T., Kurihara, T., Hayashi, T., Kohsaka, S., Kazuno, S., Sano, K., Hasegawa, N., Miura, Y., Akaike, K., et al. (2019) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201800147 · Cited by 3
Sclerostin level in rheumatoid arthritis patients and its relationship to disease severity and bone mineral density
Eman, A., Mona, A., Barakat, B., Mona, A., & Heba, B. (2018) · Egyptian Journal of Obesity Diabetes and Endocrinology · doi:10.4103/ejode.ejode_3_19 · Cited by 3
Menopause and Bone Metabolism
Brandi, M. L., & Medio, L. D. (2020) · Endocrinology · doi:10.1007/978-3-030-14782-2_19 · Cited by 3
Anabolic Agents as New Treatment Strategy in Osteoporosis
Okman, T. K., & Sagiroglu, C. (2013) · InTech eBooks · doi:10.5772/54452 · Cited by 3
Genetic analysis and effect of triiodothyronine and prednisone trial on bone turnover in a patient with craniotubular hyperostosis
López, J. M., Balemans, W., Piters, E., Hul, W. V., & González, G., V (2008) · Bone · doi:10.1016/j.bone.2008.04.011 · Cited by 3
Effects of anti-sclerostin antibody and running on bone remodeling and strength
Toumi, H., Benaîtreau, D., Pallu, S., Mazor, M., Hambli, R., Ominsky, M. S., & Lespessailles, É. (2015) · Bone Reports · doi:10.1016/j.bonr.2015.03.002 · Cited by 3
Anabolic and Catabolic Pathways of Parathyroid Hormone on the Skeleton
Silva, B. C. C., & Bilezikian, J. P. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397166-1.00015-1 · Cited by 3
Immunolocalization of sclerostin synthesized by osteocytes in relation to bone remodeling in the interradicular septa of ovariectomized rats
Guo, Y., Li, M., Zhusheng, L., Yamada, T., Sasaki, M., Hasegawa, T., Hongo, H., Tabata, C., Suzuki, R., Oda, K., et al. (2012) · Journal of Electron Microscopy · doi:10.1093/jmicro/dfs052 · Cited by 3
Gene Expression in Response to Low-Intensity Pulsed Ultrasound Treatment of Bone Marrow Cells under Osteogenic Conditions In Vitro
Yamaguchi, D., Takeuchi, K., Furuta, H., Miyamae, S., Murakami, H., & Hattori, M. (2016) · Journal of Hard Tissue Biology · doi:10.2485/jhtb.25.137 · Cited by 3
Serum sclerostin levels in renal cell carcinoma patients with bone metastases
Wibmer, C., Amrein, K., Fahrleitner‐Pammer, A., Gilg, M. M., Berghold, A., Hutterer, G. C., Maurer-Ertl, W., Gerger, A., Leithner, A., Pichler, M., et al. (2016) · Scientific Reports · doi:10.1038/srep33551 · Cited by 3
Bone Biology and Effects of Pharmaceutical Intervention on Bone Quality
Ott, S. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802792-9.00002-1 · Cited by 3
Effect of adrenocorticotropic hormone infusion on circulating sclerostin levels
Zaheer, S., Meyer, K., Easly, R., Bayomy, O., Leung, J., Koefoed, A. W., Heydarpour, M., Freeman, R., & Adler, G. K. (2021) · Endocrine Connections · doi:10.1530/ec-21-0263 · Cited by 3
Immobilization osteoporosis
Cardozo, C. P., & Bauman, W. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00040-x · Cited by 4
Wnt Signaling in Bone Development
Bodine, P. V. N. (2010) · Springer eBooks · doi:10.1007/978-1-84882-822-3_9 · Cited by 3
Bone Turnover Markers
Cavalier, E., Eastell, R., Jørgensen, N. R., Makris, K., Vasikaran, S. D., & Morris, H. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65194-2 · Cited by 4
Parathyroid hormone (1–34) retards the lumbar facet joint degeneration and activates Wnt/β-catenin signaling pathway in ovariectomized rats
Gou, Y., Li, H., Sun, X., Chen, D., & Tian, F. (2024) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-024-04817-6 · Cited by 2
Proteomic Correlates of Vitamin D Supplementation in the Atherosclerosis Risk in Communities (ARIC) Study
Sullivan, V. K., Chen, J., Bernard, L., Yu, B., Michos, E. D., Appel, L. J., Lichtenstein, A. H., & Rebholz, C. M. (2025) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.70005 · Cited by 2
Goldfish regenerated scale culture at low temperatures improves osteoblast and osteoclast survival in scales without loss of the osteoblast and osteoclast response to changes in gravity
Suzuki, N., Kuroda, K., Ikegame, M., Takino, H., Tsunoda, K., Izumi, R., Tabuchi, Y., Furusawa, Y., Yachiguchi, K., Endo, M., et al. (2025) · Life Sciences in Space Research · doi:10.1016/j.lssr.2025.04.004 · Cited by 2
The influence of titanium particles on the functionality of osteocytes in bone remodeling: An In-vitro study
Almabrok, N., Gopalakrishnan, A. R. K., Kheder, W., Kawas, S. A., & Samsudin, A. R. (2025) · PLoS ONE · doi:10.1371/journal.pone.0334156 · Cited by 2
Effects of aerobic treadmill exercise on the bone turnover in obese male mice
Du, Y., Liu, G., Zhang, L., Lin, H., Gao, B., & Zhang, L. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1650496 · Cited by 2
Therapeutic effect of mitochondrial transfer on bone tissue diseases: treatment strategy of mitochondrial transplantation and delivery technology
Wu, Z., Guan, Y., Song, R., Chen, P., Fang, X., Chen, Q., & Chen, X. (2026) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2026.101143 · Cited by 3
Effect of Zoledronate on the Responses of Osteocytes to Acute Parathyroid Hormone
Kuroshima, S., Elliott, K. W., & Yamashita, J. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9720-z · Cited by 2
Vía Wnt y esclerostina como nuevas dianas para la evaluación y el tratamiento de la osteoporosis
Alonso, G., García‐Martin, A., & Muñoz‐Torres, M. (2012) · Medicina Clínica · doi:10.1016/j.medcli.2012.03.006 · Cited by 2
Circulating Sclerostin in Disorders of Parathyroid Gland Function
Clarke, B. L. (2012) · Yearbook of Endocrinology · doi:10.1016/j.yend.2012.03.051 · Cited by 2
Neue Antiosteoporotika am Horizont
Knauerhase, A., & Willenberg, H. S. (2016) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-016-0102-6 · Cited by 2
Basics of Bone Biology
Rauner, M., & Hofbauer, L. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-34238-2_1 · Cited by 2
Characterization of sclerostin’s response within white adipose tissue to an obesogenic diet at rest and in response to acute exercise in male mice
Kurgan, N., Baranowski, B. J., Stoikos, J., MacNeil, A. J., Fajardo, V. A., MacPherson, R. E. K., & Klentrou, P. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2022.1061715 · Cited by 2
Administration of low intensity vibration and a RANKL inhibitor, alone or in combination, reduces bone loss after spinal cord injury-induced immobilization in rats
Peng, Y., Bramlett, H. M., Dietrich, W. D., Marcillo, A. E., Sanchez‐Molano, J., Furones-Alonso, O., Cao, J., Huang, J., Li, A. A., Feng, J. Q., et al. (2024) · Bone Reports · doi:10.1016/j.bonr.2024.101808 · Cited by 3
Genetic Influences and Targeted Treatments in Osteoporosis: A Systematic Review
Zurel, F., Bux, H., Diveli, A., & Rashid, Z. (2025) · Cureus · doi:10.7759/cureus.87436 · Cited by 2
Inhibitors of canonical Wnt signaling pathway and inorganic phosphate imbalance in experimental chronic kidney disease
Bogdanova, E. O., Николаевна, Б. О., Михайловна, З. И., Ivanova, G. T., Parastaeva, M., Галкина, О. В., Kayukov, I. G., & Dobronravov, V. (2019) · Nephrology (Saint-Petersburg) · doi:10.36485/1561-6274-2019-236-83-91 · Cited by 2
Hydroxyapatite Modulates mRNA Expression Profiles in Cultured Osteocytes
Hamamura, K., Zhao, L., Jiang, C., Tanjung, N., Swarnkar, G., & Yokota, H. (2012) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-012-0228-9 · Cited by 2
Sclerostin Modulation Holds Promise for Dental Indications
Hassan, M. G., Zaher, A. R., Palomo, J. M., & Palomo, L. (2018) · Healthcare · doi:10.3390/healthcare6040134 · Cited by 2
Osteocyte Biology
Bellido, T., Pajevic, P. D., & Bonewald, L. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00014-9 · Cited by 2
Differential changes in bone strength of two inbred mouse strains following administration of a sclerostin-neutralizing antibody during growth
Mathis, N. J., Adaniya, E., Smith, L., Robling, A. G., Jepsen, K. J., & Schlecht, S. H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214520 · Cited by 2
Serum sclerostin levels, arteriovenous fistula calcification and 2-years all-cause mortality in prevalent hemodialysis patients
Kırkpantur, A., Balcı, M. M., Türkvatan, A., & Afşar, B. (2016) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2016.01.005 · Cited by 2
Bone remodeling and oral rehabilitation plans with mini-implants and mini-plates: a few analogies to facilitate understanding.
Consolaro, A. G. (2015) · Dental Press Implantology · doi:10.14436/2358-2553.9.3.015-037.exp · Cited by 2
Effect of compression on mandibular fracture haematoma-derived cells
Arimoto, S., Hasegawa, T., Iwata, E., Takeda, D., & Akashi, M. (2022) · British Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.bjoms.2022.06.001 · Cited by 2
Employment of selective pharmacologically active natural compounds in treatment and management of osteoporosis
Upmanyu, V., Sapra, L., & Srivastava, R. K. (2022) · Studies in natural products chemistry · doi:10.1016/b978-0-323-91250-1.00005-7 · Cited by 2
Sclerostin and Wnt Signaling in Idiopathic Juvenile Osteoporosis Using High-Resolution Confocal Microscopy for Three-Dimensional Analyses
Pereira, R. C., Noche, K. J., Gales, B., Chen, Z., Salusky, I. B., & Albrecht, L. V. (2024) · Children · doi:10.3390/children11070820 · Cited by 3
Control of bone mass by sclerostin: Inhibiting BMP- and WNT-induced bone formation
de Gorter, D. J. J., Krause, C., ten Dijke, P., Löwik, C. W. G. M., & van Bezooijen, R. L. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8552-1_14 · Cited by 2
Self-citation
Pharmacologic basis of sclerostin inhibition
Ke, H. Z., Roberts, S. J., & Holdsworth, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00074-9 · Cited by 2
RETRACTED ARTICLE: Titanium particles damage osteocytes and inhibit osteoblast differentiation
Chen, L., Wang, Z., Xu, W., & Dong, Q. (2020) · Journal of Experimental Orthopaedics · doi:10.1186/s40634-020-00268-0 · Cited by 2
Retracted
Low Levels of Serum Sclerostin in Adult Patients With Tumor-Induced Osteomalacia Compared With X-linked Hypophosphatemia
Ni, X., Zhang, Q., Li, X., Pang, Q., Gong, Y., Wang, O., Li, M., Xing, X., Jiang, Y., & Xia, W. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab579 · Cited by 2
Development of Novel Models for Studying Osteoclasts
Thudium, C. S. (2014) · Lund University Publications (Lund University) · Cited by 2
[Is today's man really less fertile?].
Marmor, D., Izard, V., Schahmanèche, D. D., Benoît, G., & Jardin, A. (1998) · PubMed · Cited by 2
Electrospun PCL nanofibers incorporated with natural and synthetic calcium hydroxyapatite particles for tooth regeneration
Hughes, S. M. (2016) · Holmes Museum Of Anthropology (Wichita State University) · Cited by 2
Radiographic Progression in Ankylosing Spondylitis
Sarı, İ. (2018) · TSpace (University of Toronto) · Cited by 2
FGF23 and Klotho in Chronic Kidney Disease
Fajol, A., Komaba, H., & Fukagawa, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11275-9 · Cited by 2
Mechanical Properties of Bone Due to SOST Expression: A 3-Point Bending Assessment of Murine Femurs
Peterson, K. J. (2012) · doi:10.15368/theses.2012.49 · Cited by 2
The Relationship between Serum Sclerostin Levels and Bone Mineral Disorders and Vascular Calcification in Hemodialysis Patients
Abdallah, E. A., Sherif, N., Mosbah, O., Metwaly, A. A., ElAzim, I. M. A., Mahmoud, O., Farouk, M., Mamdouh, S., El-Shishtawy, S., & Mohamed, A. H. (2021) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2021.7578 · Cited by 1
Modeling Effects of Electromagnetic Fields on Bone Density on Humans in Microgravity
Lutz, K., Trevino, T., & Adrian, C. (2022) · AIAA Accelerating Space Commerce, Exploration, and New Discovery Conference (ASCEND) · doi:10.2514/6.2022-4291 · Cited by 1
Local drug delivery and periodontal regeneration: Are we in a dire strait? An original review
Singh, A. K., & Basavaraju, S. (2024) · International Journal of Applied Dental Sciences · doi:10.22271/oral.2024.v10.i1a.1895 · Cited by 1
Hindlimb Unloading Reversibly Attenuates Osteogenic Potential of Rat Skeletal Stem and Progenitor Cells ex vivo
Markina, E. A., Andreeva, E. R., & Buravkova, L. B. (2025) · Cells Tissues Organs · doi:10.1159/000545284 · Cited by 1
Effect of High Glucose and Carboxymethyl-Lysine on Osteocyte Gene Expression
Vaidya, R., Conlon, L., Duclos, O. T., Behzad, R., Aaronson, J., & Karim, L. (2025) · American Journal of Molecular Biology · doi:10.4236/ajmb.2025.152012 · Cited by 1
Isolation, Purification, Generation, and Culture of Osteocytes
Blank, M., & Sims, N. A. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4306-8_3 · Cited by 1
Epigenetic modifications in Bone metabolism: Exploring the link with osteoporosis
Suleiman, K. Y., Ahmed, H., Kigir, E. S., Ibraheem, G. H., Adio, A. A., Samuel, O. B., & Jaji, A. Z. (2025) · Human Gene · doi:10.1016/j.humgen.2025.201449 · Cited by 1
Association Between Sclerostin and Sarcopenia-Related Functional Decline in Older Women
Lee, D. G., Lee, J. H., & Kong, E. (2026) · Diagnostics · doi:10.3390/diagnostics16020272 · Cited by 1
Generation and characterization of a novel inducible Sost_P2A_CreERT2 mouse model with high specificity for osteocytes
Prideaux, M., Kitase, Y., Pelletier, S. W., Robling, A. G., & Bonewald, L. F. (2026) · JBMR Plus · doi:10.1093/jbmrpl/ziag010 · Cited by 1
Osteocyte Mechanobiology in Peri-Implant Bone Adaptation: A Narrative Review and Hypothesis-Generating Framework for SOST/Wnt-Linked Cortical Stability
Kuc, A. E., Sulewska, M. E., Hajduk, G., Kuc, P., Kuc, N., Lis, J., Kawala, B., & Sarul, M. (2026) · Cells · doi:10.3390/cells15090748 · Cited by 1
Multi-scale assessment of scaffold-guided regeneration in human extraction sockets using an ultra-porous TiO₂ biomaterial
Jamous, R., Nysæther, I., Haugen, H. J., Lyngstadaas, S. P., Fredriksson, M. V., Ellingsen, J. E., & Khassawna, T. E. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.08.041 · Cited by 1
Fisiología del tejido óseo
Thomas, T., Martin, A., & Lafage‐Proust, M. (2011) · EMC - Podología · doi:10.1016/s1762-827x(11)71060-4 · Cited by 1
SERUM CONCENTRATIONS OF PROTEIN REGULATORS OSTEOBLASTOGENESIS AND OSTEOCLASTOGENESIS IN PATIENTS WITH ENDOGENOUS HYPERCORTICISM
Belaya, Z. E., Rozhinskaya, L. Y., Dragunova, N. V., Solodovnikov, A. G., Ilyin, А. V., Mel'nichenko, G. A., Dedov, I. I., & Dzeranova, L. K. (2012) · Osteoporosis and Bone Diseases · doi:10.14341/osteo201223-8 · Cited by 1
Romosozumab/CDP7851 for the treatment of osteoporosis
Sim, I., & Ebeling, P. R. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.1079482 · Cited by 1
Quantitative in situ fluorescence imaging to unveil the morphological and functional heterogeneity of osteocytes
Lee, J.-W., & Iimura, T. (2015) · Journal of Oral Biosciences · doi:10.1016/j.job.2015.02.001 · Cited by 1
Presente y futuro de los anticuerpos monoclonales en el tratamiento de la osteoporosis
Aresté, J. F. (2011) · Reumatología Clínica · doi:10.1016/j.reuma.2011.04.003 · Cited by 1
Future of Bone Repair
Somaiya, R. D., & Kaur, G. (2015) · Bone and Tissue Regeneration Insights · doi:10.4137/btri.s12333 · Cited by 1

Authors: Poole, K. E. S., Van Bezooijen, R. L., Loveridge, N., Hamersma, H., Papapoulos, S. E., Löwik, C. W., & Reeve, J.
Affiliations: University of Cambridge (GB)
Department of Endocrinology and Metabolic Diseases Leiden University Medical Centre Leiden Netherlands
South Africa
Leiden University (NL)
ORCID: Poole, Kenneth E. S.
Loveridge, Nigel
Hamersma, Herman
Papapoulos, Socrates E.
Löwik, Clemens W.
Reeve, Jonathan
Venue: The FASEB Journal
Publisher: Wiley
Published: 2005-08-25
Volume: 19
Issue: 13
Pages: 1842-1844
ISSN: 0892-6638 (ISSN-L)
1530-6860
DOI: 10.1096/fj.05-4221fje
OpenAlex: W1970864109
Cited by: 965
References: 34
Citations by year: 2026: 21 · 2025: 28 · 2024: 32 · 2023: 39 · 2022: 38 · 2021: 45 · 2020: 74 · 2019: 63 · 2018: 55 · 2017: 53 · 2016: 66 · 2015: 67 · 2014: 55 · 2013: 62 · 2012: 63
FWCI: 10.29
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: The FASEB Journal (publishedVersion)
PubMed (publishedVersion)
Funders: Medical Research Council
National Osteoporosis Society
European Commission (LSHM‐CT‐2003‐503020)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
Keywords: sclerostin, osteocytes, bone formation inhibition, sclerosteosis, osteoblasts, bone mineralization, bone lining cells, bone turnover
MeSH terms: Aged, Alkaline Phosphatase, Antibodies, Monoclonal, Biopsy, Bone and Bones, Bone Development, Bone Diseases, Developmental, Bone Resorption, Cell Differentiation, Coloring Agents, Female, Genetic Markers, Humans, Image Processing, Computer-Assisted, Immunohistochemistry, Male, Microscopy, Fluorescence, Middle Aged, Models, Biological, Osteoblasts, Osteocytes, Osteogenesis, RNA, Messenger, Time Factors, Tolonium Chloride, Signal Transduction, Bone Remodeling, Bone Morphogenetic Proteins, Adaptor Proteins, Signal Transducing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks